Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The ACT domain family.

D M Chipman1, B Shaanan

  • 1Department of Life Sciences, Ben-Gurion University, PO Box 653, 84105, Beer-Sheva, Israel. chipman@bgumail.bgu.ac.il

Current Opinion in Structural Biology
|December 26, 2001
PubMed
Summary

The ACT domain is a newly discovered protein structure that helps regulate enzyme activity by binding to specific molecules. This summary explores how these domains fold and interact with inhibitors to control metabolic pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Poorly conserved ORFs in the genome of the archaea Halobacterium sp. NRC-1 correspond to expressed proteins.

Bioinformatics (Oxford, England)·2004
Same author

Binding and activation of thiamin diphosphate in acetohydroxyacid synthase.

Biochemistry·2001
Same author

Chemical characteristics of dimer interfaces in the legume lectin family.

Protein science : a publication of the Protein Society·2001
Same author

Acetohydroxyacid synthase: a proposed structure for regulatory subunits supported by evidence from mutagenesis.

Journal of molecular biology·2001
Same author

Analysis of intracellular metabolites as tool for studying branched-chain amino acid biosynthesis and its inhibition in bacteria.

Methods in enzymology·2000
Same author

Isolation of subunits of acetohydroxy acid synthase isozyme III and reconstitution of holoenzyme.

Methods in enzymology·2000

Area of Science:

  • Structural biology and protein engineering within ACT domain research
  • Computational biochemistry and molecular evolution

Background:

The precise mechanisms governing how proteins sense metabolic signals remain poorly understood. No prior work had resolved the structural basis for many regulatory ligand-binding modules. That uncertainty drove interest in identifying recurring motifs across diverse biological systems. Researchers previously lacked a comprehensive framework for classifying these small, versatile regulatory units. This gap motivated the search for conserved folds within protein sequences. It was already known that certain enzymes utilize C-terminal regions for feedback control. However, the evolutionary relationships between these disparate regulatory domains stayed obscure. Scientists required a clearer understanding of how these motifs facilitate allosteric inhibition in various cellular contexts.

Purpose Of The Study:

The aim of this study is to characterize the structural and functional properties of the newly identified ACT domain. Researchers sought to define the folding pattern that enables this motif to act as a regulatory unit. The investigation addresses the lack of clarity regarding how these domains facilitate ligand binding across different enzymes. This work explores the evolutionary conservation of the fold within diverse protein families. The authors intended to provide a framework for identifying similar regulatory modules in proteins with unknown structures. They aimed to compare the binding mechanisms of the archetypical 3-phosphoglycerate dehydrogenase domain with other regulatory regions. This study addresses the uncertainty surrounding the structural basis of allosteric control in metabolic pathways. The researchers motivated this analysis by highlighting the potential for complex regulation through domain repeats.

Keywords:
allosteric regulationprotein foldingstructural bioinformaticsenzyme inhibition

Frequently Asked Questions

The ACT domain functions as a regulatory module by forming an eight-stranded antiparallel sheet. Two serine molecules bind at the interface of this dimer, which acts as an allosteric inhibitor to modulate enzymatic activity within the 3-phosphoglycerate dehydrogenase system.

Researchers utilize PSI-BLAST, a computational sequence alignment tool, to identify these domains. This method detects distant evolutionary relationships by comparing amino acid sequences against known protein databases, allowing for the discovery of novel motifs like the ACT fold.

The ferredoxin-like beta-alpha-beta-alpha-beta topology is necessary for the domain to maintain its characteristic regulatory fold. This specific arrangement of secondary structures creates the stable interface required for ligand binding and subsequent allosteric control within the protein.

Related Experiment Videos

Main Methods:

Review approach involved utilizing computational sequence analysis to categorize protein motifs. The investigators employed PSI-BLAST to scan databases for conserved structural signatures. This technique allowed for the identification of the archetypical fold within 3-phosphoglycerate dehydrogenase. The team performed structural comparisons between known regulatory domains and putative candidates. They examined the spatial arrangement of beta-alpha-beta motifs to determine topological similarities. The researchers assessed the interface properties where inhibitory molecules interact with the protein surface. This approach integrated sequence-based searching with structural modeling to infer functional relationships. The study synthesized existing knowledge to map the distribution of these regulatory modules across various protein families.

Main Results:

Key findings from the literature reveal that the ACT domain adopts a characteristic ferredoxin-like beta-alpha-beta-alpha-beta topology. A dimer of these domains creates an eight-stranded antiparallel sheet structure. Two serine molecules bind at the interface of this dimer to exert allosteric inhibition. The researchers identified that rat phenylalanine hydroxylase contains a regulatory domain with a similar fold but a distinct ligand-binding mechanism. Putative domains in acetohydroxyacid synthase regulatory subunits are predicted to share this structural organization. The study demonstrates that threonine deaminase possesses a regulatory domain structurally similar to the paired 3-phosphoglycerate dehydrogenase modules. The authors observed that repeating these domains can establish non-equivalent binding sites for complex regulation. These results indicate that the fold is a conserved regulatory element found in diverse biological contexts.

Conclusions:

The authors propose that the ACT domain represents a widespread regulatory fold across multiple protein families. This structural motif likely facilitates diverse ligand-binding modes beyond the archetypical serine interaction. The researchers suggest that repeating these domains could generate complex, multi-site regulatory systems within single enzymes. Synthesis and implications indicate that even proteins with low sequence similarity might share this conserved structural architecture. The study highlights that threonine deaminase regulatory regions provide a structural parallel despite lacking sequence homology. These findings imply that ligand-binding versatility is a hallmark of this specific beta-alpha-beta fold. The authors conclude that further structural characterization is necessary to map the full functional diversity of these modules. Future investigations should focus on confirming the folding patterns of putative domains in proteins with unknown structures.

The researchers analyze structural data to compare the regulatory domains of 3-phosphoglycerate dehydrogenase and rat phenylalanine hydroxylase. While both proteins share a similar fold, the authors note that they employ distinct ligand-binding modes to achieve their regulatory effects.

The authors measure the structural similarity between the regulatory domain of threonine deaminase and the paired 3-phosphoglycerate dehydrogenase domains. They observe that these structures are comparable despite the former not belonging to the same sequence family.

The researchers propose that ACT-like domain repeats enable the creation of non-equivalent ligand-binding sites. This configuration allows for complex regulatory patterns, suggesting that proteins can fine-tune their metabolic responses through modular structural evolution.